40,905 Cardinal Health, Inc. $CAH Shares Bought by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. lifted its position in Cardinal Health, Inc. (NYSE:CAH) by 3.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,130,814 shares of the company’s stock after acquiring an additional 40,905 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Cardinal Health were worth $251,606,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the company. Prime Capital Investment Advisors LLC increased its stake in Cardinal Health by 3.5% during the third quarter. Prime Capital Investment Advisors LLC now owns 7,859 shares of the company’s stock valued at $1,749,000 after purchasing an additional 264 shares during the last quarter. Focused Alpha LLC lifted its position in shares of Cardinal Health by 6.4% in the 3rd quarter. Focused Alpha LLC now owns 2,900 shares of the company’s stock worth $645,000 after buying an additional 175 shares during the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd lifted its position in shares of Cardinal Health by 2.1% in the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 33,457 shares of the company’s stock worth $7,444,000 after buying an additional 674 shares during the last quarter. Secure Asset Management LLC boosted its holdings in shares of Cardinal Health by 1.6% in the 3rd quarter. Secure Asset Management LLC now owns 4,422 shares of the company’s stock valued at $984,000 after buying an additional 68 shares during the period. Finally, Clark Financial Services Group Inc. BD boosted its holdings in shares of Cardinal Health by 7.8% in the 3rd quarter. Clark Financial Services Group Inc. BD now owns 4,941 shares of the company’s stock valued at $1,099,000 after buying an additional 356 shares during the period. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Stock Performance

Cardinal Health stock opened at $257.15 on Wednesday. Cardinal Health, Inc. has a one year low of $156.81 and a one year high of $258.30. The company has a 50-day simple moving average of $235.21 and a 200-day simple moving average of $222.94. The firm has a market capitalization of $59.54 billion, a P/E ratio of 35.57, a P/E/G ratio of 1.52 and a beta of 0.50.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, beating the consensus estimate of $2.42 by $0.49. The firm had revenue of $63.67 billion for the quarter, compared to the consensus estimate of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. Cardinal Health’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period last year, the firm posted $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, sell-side analysts forecast that Cardinal Health, Inc. will post 12.55 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st were issued a $0.5158 dividend. The ex-dividend date was Thursday, October 1st. This represents a $2.06 annualized dividend and a dividend yield of 0.8%. Cardinal Health’s dividend payout ratio is 28.49%.

Insider Buying and Selling

In related news, CEO Jason M. Hollar sold 44,529 shares of Cardinal Health stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $236.18, for a total value of $10,516,859.22. Following the transaction, the chief executive officer directly owned 190,603 shares in the company, valued at $45,016,616.54. The trade was a 18.94% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CAO Mary C. Scherer sold 2,302 shares of Cardinal Health stock in a transaction dated Wednesday, August 19th. The stock was sold at an average price of $237.39, for a total value of $546,471.78. Following the completion of the transaction, the chief accounting officer directly owned 2,811 shares in the company, valued at $667,303.29. This represents a 45.02% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 210,271 shares of company stock worth $49,626,657 in the last ninety days. Insiders own 0.12% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. TD Cowen increased their price objective on shares of Cardinal Health from $275.00 to $280.00 and gave the stock a “buy” rating in a research note on Thursday, August 13th. Bank of America raised their target price on shares of Cardinal Health from $240.00 to $260.00 and gave the stock a “buy” rating in a report on Thursday, July 2nd. JPMorgan Chase & Co. lifted their target price on Cardinal Health from $215.00 to $260.00 and gave the company a “neutral” rating in a research note on Thursday, August 13th. Evercore reaffirmed an “outperform” rating and set a $270.00 target price on shares of Cardinal Health in a report on Wednesday, August 12th. Finally, Wells Fargo & Company increased their price target on Cardinal Health from $245.00 to $277.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 12th. Sixteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $269.38.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company that supports the distribution and delivery of pharmaceuticals, medical products and related services. The company serves hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, as well as consumer health products, to pharmacies and healthcare institutions.